Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
Oubari Pharma

November 2025

Oubari Pharma Market Share Analysis for November 2025

Oubari for Pharmaceutical Industries (Oubari Pharma) is a leading manufacturer of quality licensed and generic pharmaceuticals based in Aleppo, Syria.
Year Founded1989
Employees501 - 1000
Annual Revenue$100M - $200M
oubari.com
Oubari Pharma
Oubari Pharma (including company regionals)
  • oubari.com
    oubari.com
See more website traffic and engagement information

Oubari Pharma Revenue up to November 2025 is 100M - 200M

revenue generated by Oubari Pharma top domains

Oubari Pharma top domains revenue over 3 years

Revenue for Oubari Pharma top domains


Total visits to Oubari Pharma's top domains

Understand Oubari Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Oubari Pharma's top domains

Analyze Oubari Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Oubari Pharma's top domains

See how Oubari Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Oubari Pharma

These are the website technologies, by industry, used by Oubari Pharma top domains

Widget (8)

Twemoji

Twemoji

Social (4)

Instagram

Instagram

Content Management System (2)

WordPress

WordPress

Conversion & Analytics (2)

Google Analytics

Google Analytics

More Technologies

5

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.